Results 11 to 20 of about 25,641 (181)
Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
Open Medicine, 2018 This research is aimed to study the resistance and molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae (CRKP).
Lin Di +4 more
doaj +3 more sources
Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
Infection and Drug Resistance, 2013 Lisa Saidel-Odes,1,2 Abraham Borer1,21Infection Control and Hospital Epidemiology Unit, 2Infectious Diseases Institute, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelAbstract ...
Saidel-Odes L, Borer A
doaj +5 more sources
Reducing dissemination of carbapenem-resistant Klebsiella pneumoniae [PDF]
Annals of Translational Medicine, 2019 Besides being resistant to several β-lactams, carbapenem-resistant Klebsiella pneumoniae (CRKP) are often resistant to other widely used antimicrobials such as fluoroquinolones and cotrimoxazole, and sometimes to aminoglycosides (1,2). Although possibly not the only reason, the increased risk of delayed/suboptimal treatment consequent to the multidrug ...
Bassetti, Matteo +1 more
openaire +2 more sources
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains [PDF]
Frontiers in Microbiology, 2021 Heteroresistance can lead to treatment failure and is difficult to detect by the methods currently employed by clinical laboratories. The aim of this study was to investigate the prevalence of the amikacin-heteroresistant Klebsiella pneumoniae strains and explore potential amikacin heteroresistance mechanism through whole-genome sequencing (WGS) and ...
Feiyang Zhang +7 more
openaire +3 more sources
Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19 [PDF]
Antibiotics, 2021 Infections with carbapenem-resistant Enterobacteriaceae are emerging as an important challenge in healthcare settings. Currently, carbapenem-resistant Klebsiella pneumoniae (CRKP) are the species of CRE most commonly encountered in hospitals. CRKP is resistant to almost all available antimicrobial agents, and infections with CRKP have been associated ...
Irina Dumitru +14 more
openaire +3 more sources
Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
mSphere, 2021 Carbapenem-resistant Klebsiella ...
Kasturi Banerjee +3 more
doaj +1 more source
Virulence factors in carbapenem-resistant hypervirulent Klebsiella pneumoniae
Frontiers in Microbiology, 2023 Hypervirulence and carbapenem-resistant have emerged as two distinct evolutionary pathotypes of Klebsiella pneumoniae, with both reaching their epidemic success and posing a great threat to public health. However, as the boundaries separating these two pathotypes fade, we assist a worrisome convergence in certain high-risk clones, causing hospital ...
Gabriel Mendes +7 more
openaire +4 more sources
Detection of carbapenemase genes in Klebsiella pneumoniae isolates [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2016 Introduction. Klebsiella pneumoniae is one of the leading causes of serious hospital-acquired infections worldwide among Enterobacteriaceae species. It is the most common producer of carbapenemases in many parts of the world. Objective.
Mihajlović-Ukropina Mira +5 more
doaj +1 more source
Zhongguo linchuang yanjiu, 2023 Objective To analyze the clinical distribution of Klebsiella pneumoniae isolates, screen for the multidrug resistance of Klebsiella pneumoniae strains to commonly used antimicrobial drugs, and provide reference for the prevention and control of ...
CHEN Mingxia*, MA Yue, YANG Congshan, MENG Shanshan
doaj +1 more source
Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae [PDF]
Scientific Reports, 2017 AbstractThe expanding global distribution of multi-resistant Klebsiella pneumoniae demands faster antimicrobial susceptibility testing (AST) to guide antibiotic treatment. Current ASTs rely on time-consuming differentiation of resistance and susceptibility after initial isolation of bacteria from a clinical specimen.
K. T. Mulroney +13 more
openaire +4 more sources